| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/09/2011 | CA2474645C Compositions and methods for systemic inhibition of cartilage degradation |
| 08/09/2011 | CA2447921C Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 08/09/2011 | CA2441492C Rho-kinase inhibitors |
| 08/09/2011 | CA2438595C Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
| 08/09/2011 | CA2434484C Compositions comprising ibuprofen and diphenhydramine to treat pain-associated sleep disturbances |
| 08/09/2011 | CA2432568C Benzoylpyridazines |
| 08/09/2011 | CA2407415C Chondroitin synthase gene and methods of making and using same |
| 08/09/2011 | CA2380058C Novel peptides |
| 08/09/2011 | CA2367360C Insulin-like growth factor binding protein-4 protease |
| 08/09/2011 | CA2350340C B-cell epitopes of hsp65 and uses thereof |
| 08/04/2011 | WO2011094598A2 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| 08/04/2011 | WO2011094579A2 Mushroom compositions and methods for making and using |
| 08/04/2011 | WO2011094426A1 Caspase inhibitors |
| 08/04/2011 | WO2011093647A2 Genes implicated in osteoarthritis and use thereof |
| 08/04/2011 | WO2011093470A1 Pharmaceutical composition for treatment of bone diseases, which contains protein comprising bone morphogenetic protein receptor 1b (bmpr1b) extracellular domain or mutant thereof |
| 08/04/2011 | WO2011093083A1 Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor |
| 08/04/2011 | WO2011093082A1 Use for production of therapeutic agent or prophylactic agent for osteoarthritis |
| 08/04/2011 | WO2011093081A1 Injectable solution containing therapeutic agent for osteoarthritis |
| 08/04/2011 | WO2011092334A2 Solid/liquid extraction |
| 08/04/2011 | WO2011092329A2 Liquid/liquid extraction |
| 08/04/2011 | WO2011091973A1 5-nitro-8-hydroxyquinolines as inhibitors of cathepsin b |
| 08/04/2011 | US20110191865 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/04/2011 | US20110190730 Methods of inducing pluripotency involving oct4 protein |
| 08/04/2011 | US20110190729 Methods of inducing pluripotency involving sox2 protein |
| 08/04/2011 | US20110190397 Methods for Concomitant Administration of Colchicine and a Second Active Agent |
| 08/04/2011 | US20110190396 Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics |
| 08/04/2011 | US20110190347 Methods for treating neuropathic pain |
| 08/04/2011 | US20110190342 Glycine b antagonist |
| 08/04/2011 | US20110190319 Substituted heteroaryl fused derivatives as pi3k inhibitors |
| 08/04/2011 | US20110190308 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| 08/04/2011 | US20110190305 Optically Pure Diastereomers of 10-Propargyl-10-Deazaaminopterin and Methods of Using Same |
| 08/04/2011 | US20110190303 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 08/04/2011 | US20110190302 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use |
| 08/04/2011 | US20110190294 Novel estrogen receptor ligands |
| 08/04/2011 | US20110190292 Heterobicyclic compounds useful as kinase inhibitors |
| 08/04/2011 | US20110190290 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| 08/04/2011 | US20110190263 Compounds and compositions as modulators of gpr119 activity |
| 08/04/2011 | US20110190260 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 08/04/2011 | US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor |
| 08/04/2011 | US20110190246 Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring |
| 08/04/2011 | US20110190230 Betalain Compositions and Uses Thereof |
| 08/04/2011 | US20110190227 Antagonists of Prostaglandin D2 Receptors |
| 08/04/2011 | US20110190210 Prominin-1 peptide fragments and uses thereof |
| 08/04/2011 | US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 08/04/2011 | US20110190194 Preparation and composition of inter-alpha proteins from blood |
| 08/04/2011 | US20110189306 COMPOUNDS, COMPOSITIONS AND TREATMENTS FOR V-ATPase RELATED DISEASES |
| 08/04/2011 | US20110189304 Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects |
| 08/04/2011 | US20110189289 Cell-Based Method and Means for Rebuilding Bone |
| 08/04/2011 | US20110189285 Hydrogel capable of containing and conveying cells |
| 08/04/2011 | US20110189220 Mushroom compositions and methods for making and using |
| 08/04/2011 | US20110189212 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 08/04/2011 | US20110189211 Stem cell populations and methods of use |
| 08/04/2011 | US20110189207 Methods for soluble zalpha11 cytokine receptors |
| 08/04/2011 | US20110189206 Antibody Targeting Through a Modular Recognition Domain |
| 08/04/2011 | US20110189201 Modulation of bone development |
| 08/04/2011 | US20110189188 Novel gp96 derived peptides |
| 08/04/2011 | US20110189186 Affecting bone related conditions using cd68 blocking agents |
| 08/04/2011 | US20110189181 Use of agents derived from CEACAM1 for the treatment of inflammatory diseases |
| 08/04/2011 | US20110189177 Antibodies to vla-1 |
| 08/04/2011 | US20110189172 Methods for the treatment of rheumatoid arthritis |
| 08/04/2011 | US20110189167 Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases |
| 08/04/2011 | US20110189161 Nutrigenomics methods and compositions |
| 08/04/2011 | US20110189139 Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 Polypeptide |
| 08/04/2011 | US20110189138 Repair and/or reconstitution of invertebral discs |
| 08/04/2011 | US20110189134 Fermentation product containing equol-producing microorganism having maintained equol-producing ability, and method for producing same |
| 08/04/2011 | US20110189131 Active variants of the il-18 binding protein and medical uses thereof |
| 08/04/2011 | US20110189082 Human gm-csf antigen binding proteins |
| 08/04/2011 | CA2788527A1 Pharmaceutical composition for osteoarthritis treatment or prevention and manufacturing method therefor |
| 08/04/2011 | CA2787773A1 Liquid/liquid extraction |
| 08/04/2011 | CA2781314A1 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| 08/03/2011 | EP2351765A2 Oligonucleotide-containing pharmacological compositions and their use |
| 08/03/2011 | EP2351754A1 Phenanthroindolizidine compound and nf b inhibitor containing same as active ingredient |
| 08/03/2011 | EP2351753A1 Phenanthroindolizidine derivative and nf b inhibitor containing same as active ingredient |
| 08/03/2011 | EP2351748A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 08/03/2011 | EP2351574A1 Promoter for regeneration of tendon-bone junction tissue or ligament-bone junction tissue |
| 08/03/2011 | EP2351566A1 Pharmaceutical composition improved in absorption through intestinal tract |
| 08/03/2011 | EP2351564A1 Methods of treating an inflammatory-related disease |
| 08/03/2011 | EP2351561A2 Novel methods and compositions for alleviating pain |
| 08/03/2011 | EP2350089A1 Protease inhibitors |
| 08/03/2011 | EP2350082A1 Choline and tromethamine salt of licofelone |
| 08/03/2011 | EP2350059A2 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 08/03/2011 | EP2350031A2 Macrocyclic compounds for inhibition of tumor necrosis factor alpha |
| 08/03/2011 | EP2349990A1 Aryl-phenyl-sulfonamide-phenylene compounds and their use |
| 08/03/2011 | EP2349325A2 Protecting and repairing cartilage and musculoskeletal soft tissues |
| 08/03/2011 | EP2349281A1 Composition comprising a glycoside of a mono- or diacyiglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition |
| 08/03/2011 | EP2349248A2 Topical nsaid compositions having sensate component |
| 08/03/2011 | EP2114970B1 Tricyclic compounds and their use as glucocorticoid receptor modulators |
| 08/03/2011 | EP1878429B1 Trenadermal absorption preparation |
| 08/03/2011 | EP1534753B1 Peg positional isomer of an anti-tnfalpha antibody (cdp870) |
| 08/03/2011 | CN1891687B Inflammatory factor receptor antagonistic active compound from microbe and its use |
| 08/03/2011 | CN1846793B Tissue engineering bone and its construction and application |
| 08/03/2011 | CN102143761A Agent for treating myelofibrosis |
| 08/03/2011 | CN102140104A 1-(3-(S)-amino propyl)-piperidine-4-aminoacid amide compound and pharmaceutical composition thereof as well as preparation methods and applications of compound and pharmaceutical composition |
| 08/03/2011 | CN102140090A Dipeptidyl peptidase inhibitors |
| 08/03/2011 | CN102139099A Therapeutic composition with a botulinum neurotoxin |
| 08/03/2011 | CN102139096A Injectable biological active factor composition and preparation method and application thereof |
| 08/03/2011 | CN102139087A Medicament for treating rheumatoid arthritis and preparation method thereof |
| 08/03/2011 | CN102139077A Medicament for treating gout and preparation method thereof |
| 08/03/2011 | CN102139060A Chinese medicinal composition for treating acute urarthritis |
| 08/03/2011 | CN102139036A Traditional Chinese medicine for treating diabetic gout |